Search

Search Constraints

You searched for: Author/Creator De Paoli, Lorenzo

Search Results

1. Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. Issue 2 (27th January 2020)

3. Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. (December 2018)

4. Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment. (26th December 2021)

5. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report. Issue 4 (13th July 2021)

6. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Issue 5 (May 2013)

7. Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma. (22nd July 2021)

8. Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model. Issue 5 (25th February 2022)